Defining the Need for Dermatologic Surgery Global Health in an Afro-Caribbean Country

Ufkes, Nicole; Jacobsen, Audrey A.; Joseph, Doris J.; Macpherson, C. N. L.; Bidaisee, Satesh; deGuzman, Maryjane; Strasswimmer, John

doi:10.1097/dss.0000000000002684

Cited by 1 publication

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Caridad Center is one of the largest free clinics in the United States, offering medical, dental, and vision health services, among other opportunities, to a predominately Hispanic population. We have previously carried out a KAP study on concerns about skin cancer, which led to an intervention to improve patient outcomes [11][12][13][14]. Our goal is to assess patients' current knowledge and concerns regarding clinical trial participation, better understand barriers at the community health system level that potentially prevent minority access and representation in clinical trials, and serve as a guide for future studies on improving clinical trial diversity.…”

Section: Introductionmentioning

confidence: 99%

Knowledge, Attitudes, and Perceptions of Skin Cancer Clinical Trials in the Hispanic Population

Andrade,

Lalama,

Choragudi

et al. 2024

Cureus

Self Cite

View full text Add to dashboard Cite

Objective: To determine the factors that might limit Hispanic patients from participating in dermatological clinical trials.Methods: From January 2022 to July 2022, we administered a 31-item, in-person questionnaire to patients recruited in the waiting area of the Caridad Center, one of the largest free clinics in the United States with a predominately Hispanic population, and a nearby private primary care clinic.Results: Overall, Hispanic patients agreed significantly more with statements in the domain of attitude and behavioral beliefs compared to non-Hispanic survey respondents. The Hispanic ethnicity was associated with increased odds of agreeing with the following statements: "My community would really benefit from skin cancer clinical trials" (OR=0.52; 95% CI 0.30, 0.92), "My participation in a skin cancer study would be very good" (OR=0.59; 95% CI 0.35, 0.99), and "I like to do good for others" (OR=0.41; 95% CI 0.22, 0.77).Conclusion: While the United States population is composed of 18.5% Hispanics, they only account for 1% of patients enrolled in clinical trials. This study helps identify potential motivational factors for Hispanic patients to participate in skin cancer clinical trials.

show abstract

Section: Introductionmentioning

confidence: 99%